[HTML][HTML] Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review
HM Abdalla, AK Mahmoud, AE Khedr… - International journal of …, 2024 - mdpi.com
Lipoprotein (a) is a complex lipid molecule that has sparked immense interest in recent
years, after studies demonstrated its significant association with several cardiovascular …
years, after studies demonstrated its significant association with several cardiovascular …
[HTML][HTML] Lipoprotein (a) and the atherosclerotic burden–Should we wait for clinical trial evidence before taking action?
I Fichtner, C Macchi, AS Rizzuto, S Carugo, A Corsini… - Atherosclerosis …, 2024 - Elsevier
The fact that lipoprotein (a) levels should be regarded as a causal residual risk factor in the
atherosclerotic cardiovascular diseases (ASCVD) is now a no-brainer. This review article …
atherosclerotic cardiovascular diseases (ASCVD) is now a no-brainer. This review article …
Genetically predicted lipoprotein (a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol
SL Clarke, RDL Huang, AT Hilliard… - European Journal of …, 2025 - academic.oup.com
Abstract Aims Elevated lipoprotein (a)[Lp (a)] is a causal risk factor for atherosclerotic
cardiovascular disease, but the mechanisms of risk are debated. Studies have found …
cardiovascular disease, but the mechanisms of risk are debated. Studies have found …
EJPC@ a glance: focus issue on lipid disorders and cardiovascular prevention
C Fauvel, V Aboyans - European Journal of Preventive …, 2024 - academic.oup.com
In the study entitled 'Trends in atherosclerotic cardiovascular disease and lipid
management: a population-level observational cohort study in Wales', 1 Harris et al. found …
management: a population-level observational cohort study in Wales', 1 Harris et al. found …
Lipoprotein (a): Don't forget about secondary prevention
HS Bhatia, F Boccara - European Journal of Preventive …, 2024 - academic.oup.com
Lipoprotein (a)[Lp (a)] is an important and prevalent risk factor for atherosclerotic
cardiovascular disease (ASCVD) with multiple manifestations and implications for both …
cardiovascular disease (ASCVD) with multiple manifestations and implications for both …
[PDF][PDF] Atherosclerosis Plus
I Fichtner, C Macchi, AS Rizzuto, S Carugo, A Corsini… - air.unimi.it
The fact that lipoprotein (a) levels should be regarded as a causal residual risk factor in the
atherosclerotic cardiovascular diseases (ASCVD) is now a no-brainer. This review article …
atherosclerotic cardiovascular diseases (ASCVD) is now a no-brainer. This review article …
[引用][C] Lipoprotein (a) in clinical practice: The role in long-term in-stent restenosis
F Sbrana, B Dal Pino - Journal of Clinical Lipidology, 2024 - lipidjournal.com
Dear Editor, We read with interest Koschinsky ML et al. regarding the National Lipid
Association scientific statement on use of lipoprotein (a) in clinical practice. 1 We also want …
Association scientific statement on use of lipoprotein (a) in clinical practice. 1 We also want …